Key findings include: Mean weight loss of 24.2% (approximately 58 pounds or 26.2 kg) with 12 mg weekly dose after 48 weeks Dose-dependent efficacy across 1 mg, 4 mg, 8 mg, and 12 mg dose groups At 48 weeks, 100% of participants receiving 8 mg or 12 mg achieved at least 5% weight loss 93% of participants on 12 mg achieved 15% or more weight loss , far exceeding current therapeutic benchmarks Greater weight reduction observed in participants with BMI greater than or equal to 35 compared to those with BMI below 35 The magnitude of weight loss approaches that typically observed only with bariatric-metabolic surgery, representing a potential paradigm shift in pharmacological obesity treatment[11]
Assessing Lipid Membrane Interaction of Amyloid-Forming Proteins by Means of Colorimetric Biosensing Vesicles
Some people find that smaller, more frequent doses produce better appetite suppression with fewer GI symptoms than standard once-weekly dosing
Exercise helps preserve lean muscle mass, which is important for maintaining metabolic rate, and improves glucose uptake by skeletal muscle independent of insulin
Our guide on supplements to take with GLP-1 medications and supplements to take with tirzepatide covers safe combination strategies in detail